[HTML] nature.com

[HTML][HTML] Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based …

AF Leal, J Cifuentes, CE Torres, D Suárez… - Scientific Reports, 2022 - nature.com
Abstract Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by
mutations in the GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan …
被引用次数：10 相关文章

Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based …

AF Leal, J Cifuentes, CE Torres, D Suárez… - Scientific …, 2022 - search.ebscohost.com
Abstract Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by
mutations in the GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan …

Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based …

AF Leal, J Cifuentes, CE Torres, D Suárez… - Scientific …, 2022 - ui.adsabs.harvard.edu
Abstract Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by
mutations in the GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan …

Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based …

AF Leal, J Cifuentes, CE Torres, D Suárez… - Scientific …, 2022 - pubmed.ncbi.nlm.nih.gov
Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by mutations in the
GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan sulfate and …

Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based …

AF Leal, J Cifuentes, CE Torres, D Suárez… - Scientific …, 2022 - europepmc.org
Abstract Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by
mutations in the GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan …
[HTML] nih.gov

[HTML][HTML] Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based …

AF Leal, J Cifuentes, CE Torres, D Suárez… - Scientific …, 2022 - ncbi.nlm.nih.gov
Abstract Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by
mutations in the GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan …

Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based …

AF Leal, J Cifuentes, CE Torres, D Suárez… - Scientific …, 2022 - europepmc.org
Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by mutations in the
GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan sulfate and …